Published in Brain Res on February 10, 1980
Signaling through the M(3) muscarinic receptor favors bone mass accrual by decreasing sympathetic activity. Cell Metab (2010) 0.96
Purinergic modulation of cardiovascular function in the rat locus coeruleus. Br J Pharmacol (2005) 0.80
Individual differences in the locus coeruleus-norepinephrine system: Relevance to stress-induced cardiovascular vulnerability. Physiol Behav (2016) 0.76
The brain norepinephrine system, stress and cardiovascular vulnerability. Neurosci Biobehav Rev (2016) 0.76
Neuroinflammation at the interface of depression and cardiovascular disease: Evidence from rodent models of social stress. Neurobiol Stress (2016) 0.75
Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell (1996) 10.40
Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav (2004) 5.15
Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol (1989) 4.96
The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology (1999) 3.78
Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav (2007) 3.76
Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav (2004) 3.69
Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell (1997) 3.10
Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat Genet (1995) 2.64
Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev (1985) 2.40
Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med (1992) 2.39
Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature (2001) 2.39
Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology (Berl) (1997) 2.26
Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation. Br J Pharmacol (1971) 2.17
Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature (1996) 2.17
Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther (1973) 2.05
Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science (1997) 2.01
Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann Neurol (1989) 2.01
A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest (1999) 1.96
Social approach in genetically engineered mouse lines relevant to autism. Genes Brain Behav (2008) 1.94
Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learn Mem (1999) 1.92
Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry (1996) 1.89
Unusual repertoire of vocalizations in adult BTBR T+tf/J mice during three types of social encounters. Genes Brain Behav (2011) 1.88
International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev (1999) 1.74
Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice. Genes Brain Behav (2002) 1.70
Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci U S A (1996) 1.66
Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J Biol Chem (2000) 1.64
Acceleration of noradrenaline biosynthesis in the guinea-pig vas deferens by potassium. Br J Pharmacol (1970) 1.64
Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Nat Genet (1996) 1.63
Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nat New Biol (1973) 1.61
Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta. Proc Natl Acad Sci U S A (1998) 1.59
Selective reduction of tryptophan hydroxylase activity in rat forebrain after midbrain raphe lesions. Brain Res (1971) 1.54
Mapping quantitative trait loci for open-field behavior in mice. Behav Genet (1997) 1.54
Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav (2003) 1.54
A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science (1986) 1.53
Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice. J Clin Invest (1998) 1.49
Neurogranin null mutant mice display performance deficits on spatial learning tasks with anxiety related components. Hippocampus (2001) 1.49
Reduced scent marking and ultrasonic vocalizations in the BTBR T+tf/J mouse model of autism. Genes Brain Behav (2011) 1.46
The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog Brain Res (1990) 1.45
Choline: selective accumulation by central cholinergic neurons. J Neurochem (1973) 1.45
Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease. Exp Neurol (1997) 1.43
Reduced ultrasonic vocalizations in vasopressin 1b knockout mice. Behav Brain Res (2007) 1.42
Susceptibility to a parkinsonian toxin varies during primate development. Exp Neurol (2012) 1.41
Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav (1981) 1.40
Fetal neural graft survival. Lancet (1990) 1.40
Comment on Roth appliance. Am J Orthod Dentofacial Orthop (1993) 1.39
Spontaneous blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys. Exp Neurol (1999) 1.38
Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci (1996) 1.38
Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease. Proc Natl Acad Sci U S A (2001) 1.33
Variations in noradrenaline output with respect to stimulus frequency, train length and origin of the transmitter. Br J Pharmacol (1972) 1.32
Low stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism. Neuroscience (2010) 1.30
Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory. J Neurosci (2000) 1.30
Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Proc Natl Acad Sci U S A (1994) 1.28
Pharmacology of mesocortical dopamine neurons. Pharmacol Rev (1983) 1.27
Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology (1997) 1.25
Mechanism of the gamma-hydroxybutyrate-induced increase in brain dopamine and its relationship to "sleep". Biochem Pharmacol (1970) 1.24
Acceleration of noradrenaline biosynthesis by nerve stimulation. Life Sci (1966) 1.23
Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience (1984) 1.22
Behavioral characterization of dopamine D5 receptor null mutant mice. Behav Neurosci (2001) 1.22
Dialytrode for long term intracerebral perfusion in awake monkeys. Arch Int Pharmacodyn Ther (1972) 1.21
Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. Mol Psychiatry (2010) 1.20
Variation in noradrenaline output with changes in stimulus frequency and train length: role of different noradrenaline pools. Br J Pharmacol (1974) 1.19
Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. Arch Gen Psychiatry (1975) 1.17
In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Ther (1998) 1.16
The action of reserpine on noradrenaline biosynthesis in sympathetic nerve tissue. Biochem Pharmacol (1968) 1.16
Catecholamine metabolism, depressive illness, and drug response. Arch Gen Psychiatry (1972) 1.14
Characterization of benzodiazepine-sensitive behaviors in the A/J and C57BL/6J inbred strains of mice. Behav Genet (1994) 1.13
Nicotine receptor inactivation decreases sensitivity to cocaine. Neuropsychopharmacology (2001) 1.13
The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neuroscience (1999) 1.13
Telencephalic projections of the A8 dopamine cell group. Ann N Y Acad Sci (1988) 1.13
Biochemical and morphometric analyses show that myelination in the insulin-like growth factor 1 null brain is proportionate to its neuronal composition. J Neurosci (1998) 1.12
Anxiolytic activity of an endogenous adrenal steroid. Brain Res (1986) 1.12
Autoreceptor regulation of dopamine synthesis. Ann N Y Acad Sci (1990) 1.12
Impaired learning and motor behavior in heterozygous Pafah1b1 (Lis1) mutant mice. Learn Mem (1999) 1.11
Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion. Life Sci (1991) 1.10
The predator odor, TMT, displays a unique, stress-like pattern of dopaminergic and endocrinological activation in the rat. Brain Res (2000) 1.09
Dopamine and spatial working memory in rats and monkeys: pharmacological reversal of stress-induced impairment. J Neurosci (1996) 1.09
Rapid development of tolerance to the behavioural actions of cholecystokinin. Nature (1983) 1.09
Functional occlusion for the orthodontist. J Clin Orthod (1981) 1.09
Distinct regional and subcellular localization of adenylyl cyclases type 1 and 8 in mouse brain. Neuroscience (2007) 1.08
Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res (1990) 1.07
Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action. Prog Brain Res (2000) 1.07
Content and release of amino-acids and catecholamines in monkey brain. Nature (1969) 1.06
Gamma-hydroxybutyrate-induced increase in brain dopamine: localization by fluorescence microscopy. J Pharmacol Exp Ther (1970) 1.06
Learning impairments and motor dysfunctions in adult Lhx5-deficient mice displaying hippocampal disorganization. Physiol Behav (2001) 1.06
Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet (1986) 1.06
Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Neuroscience (2000) 1.05
Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis. Neurosci Lett (1989) 1.05
Genetic analysis of anxiety-related behaviors and responses to benzodiazepine-related drugs in AXB and BXA recombinant inbred mouse strains. Behav Genet (1995) 1.05
Evidence that central nervous system depression by 1,4-butanediol in mediated through a metabolite, gamma-hydroxybutyrate. Biochem Pharmacol (1968) 1.04
AMPAKINE enhancement of social interaction in the BTBR mouse model of autism. Neuropharmacology (2012) 1.04
The straight-wire appliance 17 years later. J Clin Orthod (1987) 1.04
Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone beta1 receptor gene. Learn Mem (1999) 1.04
Pharmacological evidence supporting a role for galanin in cognition and affect. Prog Neuropsychopharmacol Biol Psychiatry (2001) 1.03
D1 and D2 dopamine receptors independently regulate spontaneous blink rate in the vervet monkey. J Pharmacol Exp Ther (1991) 1.02
Increased turnover of norepinephrine in the rat cerebral cortex during stress: role of the locus coeruleus. Neuropharmacology (1973) 1.02
Light and heavy norepinephrine storage particles in the rat heart and in bovine splenic nerve. J Pharmacol Exp Ther (1968) 1.02
GABA levels in CSF of patients with psychiatric disorders. Am J Psychiatry (1980) 1.02
An antisense oligonucleotide reverses the footshock-induced expression of fos in the rat medial prefrontal cortex and the subsequent expression of conditioned fear-induced immobility. J Neurosci (1999) 1.01
The neurosteroid pregnenolone sulfate blocks NMDA antagonist-induced deficits in a passive avoidance memory task. Psychopharmacology (Berl) (1994) 1.01
Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway. J Pharmacol Exp Ther (1973) 1.01